Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Canopy Growth Expands European Medical Cannabis Supply Into the UK

$CGCPress releaseSep 22, 2026, 7:30 AM ETRead the release

Canopy Growth will supply four Canadian-grown medical cannabis flower strains to GROW Group U.K. Ltd. for distribution in the United Kingdom, marking the company's entry into the UK medical cannabis market. GROW Group, a British manufacturer and distributor of prescribed cannabis-based medicines, will commercialize the products under Canopy Growth's global Spectrum Therapeutics medical brand.

Key figures

Uk market entry
Yes
Flower strains supplied
4

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.